4Pouton CW. Formulation of self-emulsifying drug delivery system [J]. Adv Drug Deliv Rev, 1997,25:47 -58.
5Pouton CW. Lipid formulations for oral administration of drugs: non-emusifying, self-emulsifying and “self-microemulsifying" drug delivery systems [J]. Eur J Pharm Sci, 2000,11:S93 - 98.
6O' Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery [J]. Eur J Pharm Sci, 2002, 15:405 -415.
7Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment [J]. Int J Pharm, 2001,212:233 -246.
8Constantinides PP. Lipid microemulsions for improved drug dissolution and oral absorption: physical and biopharmaceutical aspects [J]. Pharm Res, 1992, 12 :1561 - 1571.
9Sakai M, Imai T, Ohtake H, et al. Effect of absorption enhancers on cytoskeletal actin filaments in caco-2 cell monolayers [J]. Life Sci, 1998,63:45 -54.
10Liu DZ, Lecluyse EL, Thakker DR. Dodecylphosphocho-line-mediated enhancement of paracellular permeability and cytotoxicity in caco-2 cell monolayers [J]. J Pharm Sci, 1999,88:1161 - 1168.
6Kunes M,Svoboda Z,Kvetina J,et al.Intestinal single-pass in situperfusion technique in rat:The influence of L-camifine on absorptionof 7-methoxytacrine[J]. Biomed Pap Med Fac Univ Palacky Olo-mouc Czech Repub,2005.
